|
PIP5K1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.189800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.064580E-03 |
| Normal-vs-Stage2 |
2.837900E-04 |
| Normal-vs-Stage3 |
2.204000E-03 |
| Normal-vs-Stage4 |
3.728100E-02 |
| Stage1-vs-Stage2 |
1.190040E-01 |
| Stage1-vs-Stage3 |
6.464800E-01 |
| Stage1-vs-Stage4 |
5.201800E-01 |
| Stage2-vs-Stage3 |
2.911200E-01 |
| Stage2-vs-Stage4 |
6.438100E-02 |
| Stage3-vs-Stage4 |
3.812000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.242720E-03 |
| Normal-vs-AfricanAmerican |
6.894400E-01 |
| Normal-vs-Asian |
5.861600E-03 |
| Caucasian-vs-AfricanAmerican |
6.258100E-02 |
| Caucasian-vs-Asian |
7.679800E-01 |
| AfricanAmerican-vs-Asian |
4.480000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.620300E-04 |
| Normal-vs-Female |
6.167500E-04 |
| Male-vs-Female |
6.900000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.658500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.614390E-04 |
| Normal-vs-Age(61-80Yrs) |
1.879880E-03 |
| Normal-vs-Age(81-100Yrs) |
7.403800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.189380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.075200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.659400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.912200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.733180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.439000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.789800E-02 |
| Classical-VS-Follicular |
1.75636999999451E-05 |
| Classical-VS-Other |
3.361800E-01 |
| Classical-VS-Normal |
1.889580E-02 |
| Tall-VS-Follicular |
4.903800E-01 |
| Tall-VS-Other |
9.110800E-01 |
| Tall-VS-Normal |
2.415800E-03 |
| Follicular-VS-Other |
6.361200E-01 |
| Follicular-VS-Normal |
3.95200000002927E-06 |
| Other-VS-Normal |
1.013590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.06450000042702E-07 |
| Normal-vs-N1 |
2.898200E-02 |
| N0-vs-N1 |
2.916400E-02 |
|
|
